New pill for stiff heart condition enters human testing
Disease control
Recruiting now
This early-stage trial tests a new drug called VS-041 in 42 people aged 50 and older who have a type of heart failure where the heart pumps normally but is too stiff (HFpEF). The main goals are to check if the drug is safe and to measure changes in certain blood markers linked to…
Phase: PHASE1 • Sponsor: Vasa Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC